David P Meeker sold $5.1M of Rhythm Pharmaceuticals (RYTM)

Executed Sep 14, disclosed Sep 14, the same day.

Value, as filed

$5.1M

50,000 sh across 5 lots

Executed

Sep 14

the trade date, as filed

Disclosed

Sep 14

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DM David P Meeker President and CEO profile →

David P Meeker (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Rhythm Pharmaceuticals, Inc. (RYTM). The largest single filing was $5.1M of RYTM (50,000 sh across 5 lots, as filed), executed Sep 14.

The name

RYTM Rhythm Pharmaceuticals, Inc. RYTM · Healthcare · 47 filings in 24 months ticker →

Healthcare · Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United State…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by David P Meeker in RYTM

RYTMSALE Rhythm Pharmaceuticals, Inc. $2.8M
43,346 sh × $65.04
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $566K
9,896 sh × $57.22
Exec Feb 19 2025
Filed Feb 19 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $254K
4,278 sh × $59.43
Exec Feb 4 2025
Filed Feb 4 2025 · 5:30 PM ET